While multiple studies have shown that CYP1A1 genetic polymorphisms (CYP1A1 Msp I and CYP1A1 Ile/Val) could be risk factors for esophageal, gastric, and colorectal cancers [87], the current data remain controversial. The gene discussed is CYP1A1; the disease is colorectal cancer.